Final Results of the Ncri Cll210 Trial of Alemtuzumab, Dexamethasone and Lenalidomide in Patients with High-Risk Cll (Original Protocol)
Pettitt, A Polydoros, F Dodd, J Oates, M Lin, K Kalakonda, N McCarthy, H Bloor, Adrian Schuh, A Duncombe, A
Pettitt, A
Polydoros, F
Dodd, J
Oates, M
Lin, K
Kalakonda, N
McCarthy, H
Bloor, Adrian
Schuh, A
Duncombe, A
Citations
Altmetric:
Abstract
Description
Date
2016
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Final Results of the Ncri Cll210 Trial of Alemtuzumab, Dexamethasone and Lenalidomide in Patients with High-Risk Cll (Original Protocol). 2016, 101:726-726 Haematologica